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Abstract 
Background: With increasing concerns over the environment, biological production of cadaverine has been sug-
gested as an alternative route to replace polyamides generated from the petroleum-based process. For an ideal bio-
process, cadaverine should be produced with high yield and productivity from various sugars abundant in biomass. 
However, most microorganisms are not able to efficiently metabolize other biomass-derived sugars as fast as glu-
cose. This results in reduced growth rate and low carbon flux toward the production of desired bio-chemicals. Thus, 
redesign of microorganisms is necessary for utilizing those carbon sources with enhanced carbon flux and product 
formation.
Results: In this study, we engineered Escherichia coli to produce cadaverine with rapid assimilation of galactose, a 
promising future feedstock. To achieve this, genes related to the metabolic pathway were maximally expressed to 
amplify the flux toward cadaverine production via synthetic expression cassettes consisting of predictive and quan-
titative genetic parts (promoters, 5′-untranslated regions, and terminators). Furthermore, the feedback inhibition of 
metabolic enzymes and degradation/re-uptake pathways was inactivated to robustly produce cadaverine. Finally, the 
resultant strain, DHK4, produced 8.80 g/L cadaverine with high yield (0.170 g/g) and productivity (0.293 g/L/h) during 
fed-batch fermentation, which was similar to or better than the previous glucose fermentation.
Conclusions: Taken together, synthetic redesign of a microorganism with predictive and quantitative genetic parts 
is a prerequisite for converting sugars from abundant biomass into desired platform chemicals. This is the first report 
to produce cadaverine from galactose. Moreover, the yield (0.170 g/g) was the highest among engineered E. coli 
systems.
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Background
Cadaverine (1,5-diaminopentane) is an important plat-
form chemical because it can be utilized to produce vari-
ous important materials such as biopolymers, chelating 
agents, and other additives [1–3]. A promising polyam-
ide, PA 5,10, whose properties are similar to nylon 6,6 
can be polymerized from cadaverine with sebacic acid 
derived from plant oil [2]. The growing market size of 
biopolymers and bioplastics, which is expected to reach 
5.08 billion US dollars by 2021 [4], also supports the 
importance of cadaverine production. Thus, development 
of an efficient process to produce cadaverine is strongly 
required, and various biomass-derived sugars should be 
utilized to fulfill the huge demand [5].
In nature, microorganisms produce cadaverine to 
adapt to changes in their environment, such as a drop 
of pH, for their survival [6]. Throughout the last decade, 
efforts have been made to enhance cadaverine produc-
tion through metabolic engineering of industrial micro-
organisms. As an initial attempt, Escherichia coli has 
been studied for its tolerance of high concentrations of 
cadaverine [1]. This study demonstrated that E. coli is a 
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suitable host to produce cadaverine because it can grow 
even in the presence of 20–50  g/L cadaverine. In addi-
tion, flux toward cadaverine synthesis was amplified by 
overexpression of enzymes including endogenous lysine 
decarboxylase (encoded by cadA) and disruption of deg-
radation pathways. Furthermore, 9.6 g/L cadaverine was 
produced with a yield of 0.12 g cadaverine/g glucose and 
a productivity of 0.32  g/L/h [1]. Cadaverine production 
was further increased to 12.6 g/L with the expression of a 
synthetic small regulatory RNA mainly repressing murE 
[7]. A more recent study investigating systems metabolic 
engineering on lysine-producing Corynebacterium glu-
tamicum demonstrated an industrial-scale application 
with a noteworthy production [2]. However, these prom-
ising results were based on utilization of glucose mainly 
obtainable from edible food sources, which may not be 
a sufficient feedstock for platform chemical production 
due to the possible impact on food supply and security 
[8]. Although there was an effort to engineer E. coli to 
directly utilize cellobiose obtainable from cellulose for 
cadaverine production [9], the production was relatively 
low (0.62 g/L) indicating that there is a significant room 
for improvement. Therefore, more studies on the utiliza-
tion of various sugars from other inedible biomass are 
required to diversify feedstocks.
Production of cadaverine from galactose is quite prom-
ising because galactose can be easily found from the 
hydrolysate of macroalgae or dairy waste [10–12]. Par-
ticularly, macroalgae is not an edible biomass and does 
not require any fertilizer and arable land for its cultiva-
tion [13, 14]. Thus, it is expected that galactose can be a 
suitable feedstock to produce various platform chemi-
cals in large quantities. However, the major drawback of 
industrial microorganisms such as E. coli is the slower 
utilization rate of galactose than that of glucose [15]. This 
low assimilation rate of galactose results in reduced rates 
of both growth and product formation even with well-
performed glucose-dependent production pathways [16]. 
To overcome the limitation on galactose utilization, sev-
eral combinatorial approaches have been demonstrated 
such as expression of several combinations of metabolic 
genes on C. glutamicum [17] and construction of frag-
mented chromosomal library perturbations for inverse 
metabolic engineering as well as a random mutagen-
esis approach on Saccharomyces cerevisiae [18, 19]. In a 
recent study, E. coli was re-designed by reconstruction 
of its utilization pathway with synthetic genetic parts 
including predictable promoters, 5′-untranslated regions 
(5′-UTRs), and terminators to achieve maximum expres-
sion [15]. The engineered strain showed a significantly 
enhanced growth rate (44.8%) and sugar utilization rate 
(53.1%), similar to glucose fermentation [15]. Further-
more, this engineered pathway was shown to be efficient 
when combined with the n-butanol production pathway 
[20].
In this study, we develop a novel E. coli capable of pro-
ducing cadaverine from galactose, a promising future 
feedstock. To achieve this, we re-construct the entire 
galactose utilization and cadaverine production pathways 
with synthetic expression cassettes for maximum activ-
ity. Each gene is expressed under the control of synthetic 
promoters, rationally designed synthetic 5′-UTRs, and 
terminators at both transcription and translation levels. 
In addition, eliminating feedback inhibition of metabolic 
enzymes and competing metabolic pathways improve 
cadaverine production. In addition, our fed-batch fer-
mentation demonstrates that E. coli is successfully re-
designed for conversion of galactose into cadaverine.
Results
Design of synthetic expression cassettes for cadaverine 
production
Biological synthesis of cadaverine is mainly achieved 
through decarboxylation of l-lysine, one of the essential 
amino acids [21]. In order to increase flux towards cadav-
erine production, we re-constructed the metabolic path-
ways of E. coli W3110 from aspartate to lysine by adding 
synthetic expression cassettes on chromosomes (Fig. 1). 
Additionally, instead of using 4 native enzymes (encoded 
by dapD, argD, dapE, and dapF), we used meso-diami-
nopimelate dehydrogenase (encoded by ddh) from C. 
glutamicum to directly convert 4-hydroxy-tetrahydrodi-
picolinate to meso-2,6-diaminopimelate. Moreover, the 
feedback inhibition of native enzymes was released by 
introducing point mutations based on previous studies 
(C352T on dapA [22] and C1055T on lysC [23]). Finally, 
a total of six genes (asd, dapAfbr, dapB, ddh, lysA, and 
lysC fbr) were chosen to be under the control of synthetic 
expression designs on chromosome (Fig. 1).
To express those genes, a strong constitutive pro-
moter (BBa_J23100 from the Registry of Standard Bio-
logical Parts) was chosen because it does not require 
the addition of expensive inducers such as IPTG and its 
strong activity has been already adapted in the produc-
tion of various value-added chemicals [24, 25]. In addi-
tion, synthetic 5′-UTRs for each gene were designed 
using UTR Designer to achieve maximum level at trans-
lation (Additional file 1: Table S1) [26]. Then, all genetic 
parts including promoters, 5′-UTRs, coding sequences, 
and terminators were assembled as a pseudo-operon 
in a plasmid (pACYC-Lys). Subsequently, this artificial 
operon was integrated into the chromosome as an addi-
tional copy by replacing galR to increase the galactose 
utilization rate [15]. For efficient recombination, lysA, 
which is next to galR in the genome, was also deleted. The 
cassette for lysC fbr was excluded in the artificial operon 
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because we failed to obtain a proper positive colony 
during the cloning step. Possibly, harboring the consti-
tutively expressing lysC fbr cassette along with other cas-
settes on the plasmid was a severe metabolic burden. 
Instead, we replaced the native chromosomal lysC cas-
sette with the synthetic cassette of lysC fbr by homologous 
recombination.
Lastly, we expressed cadA, which converts lysine to 
cadaverine on high copy plasmids (pETduet) rather than 
chromosomal expression to increase the conversion effi-
ciency similar to a previous study [1]. Originally, cadA-
v1 (Additional file 1: Table S1) was designed as a 5′-UTR 
for cadA to achieve maximum expression. However, we 
did not successfully get a positive clone due to non-spe-
cific mutations around the promoter and 5′-UTR, as also 
observed in a previous study [1]. Therefore, we designed 
other versions of 5′-UTRs (cadA-v2 and cadA-v3, Addi-
tional file  1: Table S1) with lower expression levels. We 
obtained cadA with cadA-v3 whose predicted expression 
level was 30 times lower than that of cadA-v1.
Enhanced galactose utilization for cadaverine production
We first evaluated cadaverine production from galac-
tose for the DHK1 strain harboring pET-cadA and the 
DHK2 strain with pET-cadA and synthetic expression 
cassettes for cadaverine production on chromosomes. 
The DHK1 strain grew relatively better than the DHK2 
strain, indicating that expression of the synthetic cas-
settes for cadaverine production is a metabolic burden 
(Fig.  2a). The DHK1 strain did not produce any detect-
able amount of cadaverine despite the presence of all 
metabolic enzymes (Fig. 2c). However, the DHK2 strain 
produced significant amounts of cadaverine from galac-
tose in terms of titer, yield, and productivity (Fig.  2d, 
1.84 g/L, 0.0918 g/g, 0.0612 g/L/h, respectively).
We further engineered the native galactose operon 
(galETKM), pgm, and galP by replacing the original 
expression systems with synthetic expression cassettes. 
To achieve this, the synthetic galactose operon (galE-
galT-galK-galM), pgm, and galP were introduced to their 
original loci on the chromosome based as previously pub-
lished [15]. This DHK3 strain showed a slightly increased 
specific growth rate compared to the DHK2 strain (Fig. 2a) 
However, the maximum specific galactose uptake rate 
of the DHK3 strain (0.914  g/g DCW/h) was remarkably 
higher than that of both the DHK1 (0.477  g/g DCW/h, 
192%) and DHK2 (0.485  g/g DCW/h, 188%) strains 
(Fig. 2b). Moreover, this strain produced cadaverine with 
higher titer (2.03 g/L), yield (0.102 g/g), and productivity 
(0.0678 g/L/h) than those of the DHK2 strain (Fig. 2e). This 
Redesigned chromosomal production pathway
Galactose Cadaverine
Glycolysis
Galactose
utilization
Cadaverine
formation
TCA cycle
expression
Strong promoter (BBa_J23100)
Synthetic 5’-UTR sequences
Terminator
cadA
Deleted genes for enhanced productiongalE
Repressor
galT galK galM galP pgm
Redesigned chromosomal Leloir pathway
asd dapAfbr dapB ddh lysA lysCfbr
Fig. 1 Overall strategy to develop the E. coli strain for cadaverine production from galactose. The native galactose metabolism was replaced 
through introduction of a re-designed Leloir pathway (galE, galT, galK, galM, galP, and pgm) on the chromosome. For cadaverine production, the 
carbon flux toward lysine was amplified by additional introduction of the re-designed production pathway (asd, dapAfbr, dapB, ddh, lysA, and lysCfbr) 
on the chromosome. Then, cadaverine was produced by expression of cadA (encoding lysine decarboxylase) on a high copy plasmid. The super-
scripts of two genes (dapA and lysC) indicate deregulation of feedback inhibition by site-directed mutagenesis
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improvement indicates that galactose was successfully uti-
lized and converted to cadaverine through our re-designed 
metabolic pathway with synthetic expression cassettes.
Deletion of genes for cadaverine degradation 
and re‑uptake
Our next step was inactivation of competing path-
ways to increase cadaverine production by prevent-
ing possible degradation and re-uptake of cadaverine. 
It is known that several enzymes whose substrates are 
diamines can degrade cadaverine because of structural 
similarities to cadaverine [1]. These enzymes are putres-
cine/cadaverine aminopropyl transferase (encoded by 
speE), spermidine acetyltransferase (encoded by speG), 
γ-glutamylputrescine synthetase (encoded by puuA), 
and cadaverine aminotransferase (encoded by ygjG) 
[1, 27, 28]. In addition, putrescine importer (encoded 
by puuP) might non-specifically import extracellular 
cadaverine into the cytosol [1]. As deletion of those five 
genes led to an increase in cadaverine production [1], we 
also removed them from the chromosome of the DHK3 
strain, and this strain was designated as the DHK4 strain. 
We observed increased cadaverine titer and productiv-
ity from galactose to 2.67 g/L and 0.0892 g/L/h (Fig. 3), 
which was 31.5% higher than the parental DHK3 strain. 
The yield was also enhanced to 0.134  g/g, indicating 
effective cadaverine production with minimization of the 
degradation and re-uptake of cadaverine.
Fed‑batch cultivation of the DHK4 strain
Fed-batch cultivation of the DHK4 strain was carried out 
to evaluate its performance in large-scale fermentation. 
We used a continuously stirred 5 L reactor with 2 L of ini-
tial medium volume with pH–stat mode. After inocula-
tion, the cells immediately started to produce cadaverine. 
In the early phase during the first 12 h, the titer reached 
to 1.22  g/L and productivity was 0.101  g/L/h (Fig.  4). 
Cadaverine production accelerated with increased bio-
mass, and productivity was observed during 12–30  h 
(0.421 g/L/h). Throughout the 30-h fermentation period, 
the final titer, yield, and productivity were significantly 
higher than flask-scale batch culture (8.80 g/L, 0.170 g/g, 
and 0.293 g/L/h, respectively).
Discussion
By nature, microorganisms have evolved for rapid growth 
by fast utilization of the preferred carbon source. In 
addition, tight regulations on metabolic pathways by 
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Fig. 2 a Specific growth rate and b maximum specific galactose uptake rate of DHK 1–3 strains. One OD600 unit corresponds to 0.27 g dry cell 
weight (DCW)/L [15]. c–e Time-course fermentation profiles of DHK1-3 strains. The left y-offset, right y-axis, and right y-offset represents galactose, 
cadaverine, and acetate concentrations (g/L), respectively. The left y-axis represents OD600. The x-axis represents the culture time (h). The error bars 
indicate standard deviations of measurements from two independent cultures. Symbols: open rectangle, OD600; open circle, galactose; closed upward 
triangle, cadaverine; closed downward triangle, acetate
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chemical-responsive transcription factors [29–31], ribos-
witches [32], and feedback inhibition [33] allow efficient 
carbon allocation and a reduction in wasted resources. 
This robustness of the metabolic network often incurs 
difficulties in the redesign of microorganisms as chemi-
cal-producing cell factories. Therefore, native metabolic 
networks should be altered through modification of 
fluxes toward both desired and unwanted pathways [20, 
24, 34].
With the recent advances in synthetic biology, vari-
ous predictive and quantitative genetic elements to con-
trol the expression of specific gene(s) are now available, 
and these tools can be efficiently utilized to redesign 
microorganisms. Depending on the required strength, 
the transcription machinery can be chosen from a syn-
thetic promoter library [35–37]. Similarly, the 5′-UTR 
sequence, which is critical for translation initiation, can 
be precisely designed with consideration of the upstream 
coding sequence [26, 38]. As demonstrated in this study, 
we are now able to easily design and build synthetic 
pathways with maximum metabolic activity in a rational 
manner (galactose utilization and cadaverine production 
pathways). Moreover, the initial design can be further 
refined by modifying the design criteria as shown in the 
case of cadA. Accordingly, we successfully re-designed 
the metabolic pathways to produce cadaverine from 
galactose, resulting in the development of the DHK4 
strain, which demonstrated high titer (8.80  g/L), yield 
(0.170 g/g), and productivity (0.293 g/L/h). These results 
are similar to those of glucose-based fermentation, dem-
onstrating the highest yield ever studied in E. coli.
Although a fair amount of acetate (4.99 g/L) was still 
observed in the flask culture, it was significantly lower 
than that of the previous study [1]. When the fed-batch 
culture was conducted, 3.29-fold of cadaverine was pro-
duced compared to the batch culture while only 1.26-
fold of acetate was accumulated. It is plausible that 
controlled aeration to maintain the saturated dissolved 
oxygen level in a bioreactor might help to enhance the 
activity of the electron transport chain for synthesizing 
ATP [39]. In addition, using synthetic and controllable 
genetic parts, carbon flux might be increasingly accel-
erated toward cadaverine formation even with reduced 
acetate formation. These results support the engineered 
DHK4 strain, which led to improved cellular perfor-
mance with an increased yield. Alternatively, chromo-
somal deletion of ackA-pta, a main pathway for acetate 
production, is a possible trial as previously described 
[40, 41]. However, this deletion should be carefully 
applied as it sometimes causes reduced target chemical 
production with changes in growth pattern, although 
acetate production is significantly decreased [16]. Alter-
natively, replenishment of a key intermediate in the TCA 
cycle such as oxaloacetate can be an option to directly 
supply a precursor for cadaverine production and energy 
generation [42]. Therefore, optimal carbon flux distri-
bution around the phosphoenolpyruvate–oxaloacetate 
node can presumably enhance the production of cadav-
erine from galactose. Optimization might be achieved by 
controlling the activity of anaplerotic enzymes such as 
PEP carboxylase [38].
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Fig. 3 Time-course fermentation profiles of the DHK4 strain. The left 
y-offset, right y-axis and right y-offset represent galactose, cadaver-
ine, and acetate concentrations (g/L), respectively. The left y-axis 
represents OD600. The x-axis represents the culture time (h). The 
error bars indicate the standard deviations of measurements from 
two independent cultures. Symbols: open rectangle, OD600; open 
circle, galactose; closed upward triangle, cadaverine; closed downward 
triangle, acetate
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Fig. 4 Time-course fed-batch fermentation profile for the DHK4 
strain. The left y-offset and right y-axis represents galactose and 
cadaverine, acetate concentrations (g/L), respectively. The left y-axis 
represents OD600. The x-axis represents the culture time (h). Symbols: 
open rectangle, OD600; open circle, galactose; closed upward triangle, 
cadaverine; closed downward triangle, acetate
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Conclusions
In summary, we re-constructed the metabolic path-
way of E. coli, using synthetic expression designs to 
efficiently produce cadaverine from galactose. Addi-
tional improvement on cadaverine production was 
achieved by removing cadaverine degradation and 
re-uptake pathways. From fed-batch fermentation, 
our engineered strain showed 8.80  g/L of cadaverine 
production with 0.170 g/g of yield and 0.293 g/L/h of 
productivity. To our best knowledge, this is the first 
report to produce cadaverine from galactose with 
the yield for cadaverine production being the highest 
compared to those of previous studies in engineered 
E. coli.
Methods
Chemical reagents and oligonucleotides
Phusion DNA polymerase and restriction endonu-
cleases were purchased from New England Biolabs 
(Ipswich, MA, USA). The oligonucleotides were syn-
thesized by Cosmogenetech (Seoul, Korea) and listed 
in Additional file 1: Table S2. The amplified PCR prod-
ucts were purified using the GeneAllR Expin™ Gel SV 
kit (GeneAll Biotechnology, Seoul, Korea). Genomic 
DNA was extracted using the GeneAllR Exgene™ Cell 
SV kit. Plasmids were prepared using the AccuPrepR 
Nano-Plus Plasmid Mini Extraction Kit (Bioneer, Dae-
jeon, Korea). Other chemical reagents used in this 
study were obtained from Sigma-Aldrich (St. Louis, 
MO, USA).
Construction of strains and plasmids
The strains and plasmids used in this study are listed in 
Table 1. To construct the pACYC-Lys plasmid, the arti-
ficial lysine operon was designed using a strong consti-
tutive promoter (BBa_J23100) and the synthetic 5′-UTR 
predicted by the UTR Designer (http://sbi.postech.ac.kr/
utr_designer) to maximally express genes related to 
lysine pathways [26, 38]. The lysC, asd, dapA, dapB, and 
lysA genes were amplified from the genomic DNA of E. 
coli W3110 by PCR reaction with V-lysC-F/V-lysC-R, 
V-asd-F/V-asd-R, V-dapA-F/V-dapA-R, V-dapB-F/V-
dapB-R, and V-lysA-F/V-lysA-R primer pairs. The ddh 
was also amplified from the genomic DNA of C. glutami-
cum with V-ddh-F and V-ddh-R primers. Site-directed 
mutagenesis on dapA and lysC was conducted with 
P-dapA-F/P-dapA-R and P-lysC-F/P-lysC-R primer pairs 
via TA cloning. The amplified asd fragment was digested 
with XbaI and SphI endonuclease and this was inserted 
into the pACYCDuet plasmid. Likewise, dapAfbr, dapB, 
ddh, and lysA fragments were digested with SphI and 
SacI, SacI and NotI, NotI and KpnI, and KpnI and PacI 
endonucleases, respectively, and sequentially inserted 
into proper cloning sites to yield the pACYC-Lys plas-
mid. To construct the pET-cadA plasmid, cadA was 
amplified from the genomic DNA of E. coli W3110 using 
the V-cadA-F/V-cadA-R pair. It was then digested with 
BamHI and PacI endonucleases and inserted into a pET-
duet plasmid.
All chromosomal manipulations were conducted using 
the Lambda Red recombination system with either the 
Table 1 Strains and plasmids used in this study
Name Relevant characteristics Source
Strains
 Mach1-T1R F− φ80(lacZ)ΔM15 ΔlacX74 hsdR(rK-mK +) ΔrecA1398 endA1 tonA Invitrogen
 W3110 F- λ- rph-1 IN(rrnD, rrnE)1 ATCC 27325
 DHK1 W3100 rpsL (A128G)/pET-cadA This study
 DHK2 DHK1 PgalR-UTRgalR-galR-PlysA-UTRlysA-lysA:: PBBa_J23100-SynUTRasd-asd-PBBa_J23100-SynUTRdapA-dapA
fbr-PBBa_J23100-SynUTRdapB-
dapB-PBBa_J23100-SynUTRddh-ddh-PBBa_J23100-SynUTRlysA-lysA PlysC-UTRlysC-lysC:: PBBa_J23100-SynUTRlysC-lysC
fbr
This study
 DHK3 DHK2 galETKM:: PBBa_J23100-SynUTRgalE-galE-PBBa_J23100-SynUTRgalT-galT-PBBa_J23100-SynUTRgalK-galK-PBBa_J23100-SynUTRgalM-
galM PgalP-UTRgalP::PBBa_J23100-SynUTRgalP Ppgm-UTRpgm::PBBa_J23100-SynUTRpgm
This study
 DHK4 DHK3 ΔspeE ΔspeG ΔygjG ΔpuuPA This study
Plasmids
 pKD46 Red recombinase expression vector, AmpR [43]
 pCP20 FLP expression vector, AmpR, CmR [43]
 pETduet Expression vector, ColE1 ori, AmpR Novagen
 pACYCduet Expression vector, p15A ori, CmR Novagen
 pACYC-Lys p15A ori, CmR, PBBa_J23100-SynUTRasd-asd- PBBa_J23100-SynUTRdapA-dapA- PBBa_J23100-SynUTRdapB-dapB
fbr- PBBa_J23100-SynU-
TRddh-ddh- PBBa_J23100-SynUTRlysA-lysA
This study
 pET-cadA ColE1 ori, AmpR, PBBa_J23100-SynUTR(v3)cadA–cadA This study
 pACYC-
galO
p15A ori, CmR, FRT-KanR-FRT-PBBa_J23100-SynUTRgalE-galE-PBBa_J23100- 
SynUTRgalT-galT-PBBa_J23100-SynUTRgalK-galK-PBBa_J23100-SynUTRgalM-galM
[15]
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rpsL-neo or FRT-KanR-FRT fragment with pKD46 and 
pCP20 plasmids as previously described [40, 43–45]. 
For recombination with an rpsL-neo fragment, an rpsL 
A128G mutation was inserted into strain W3110 by 
direct recombination with the P-A128G oligonucleo-
tide. The DHK1 strain was constructed by transforming 
the pET-cadA plasmid. To develop the DHK2 strain, we 
deleted a chromosomal region from galR to lysA by inte-
grating the rpsL-neo fragment amplified with D1-galR-F/
D1-galR-R primers. The PCR fragment containing syn-
thetic expression cassettes for asd, dapAfbr, dapB, ddh, 
and lysA was prepared by amplification with O-lysO-
F/O-lys-R primers, using pACYC-Lys as a template, and 
this was integrated into the aforementioned region. In 
the case of lysC, native lysC was deleted by inserting the 
rpsL-neo fragment amplified with D1-lysC-F/D1-lys-R 
primers. The amplified lysC fbr fragment amplified with 
O-lysC-F/O-lysC-R primers was then integrated into the 
original site.
To construct DHK3 strain, the native galETKM operon 
was deleted by inserting the FRT-KanR-FRT fragment 
amplified by D1-galETKM-F/D1-galETKM-R primers. 
Next, the refactored galETKM [15] was integrated by 
inserting the PCR fragment amplified with O-galETKM-
F/O-galETKM-R primers, and pACYC-galO as a tem-
plate. In addition, both galP and pgm were overexpressed 
using the FRT-KanR-FRT fragment amplified with 
O-galP-F/O-galP-R1/O-galP-R2 and O-pgm-F/O-pgm-
R, respectively.
The DHK4 strain was developed by deleting competing 
pathways for cadaverine synthesis [1]. To delete the speE, 
speG, ygjG, and puuPA genes, proper rpsL-neo fragments 
were utilized following amplification with D1-speE-
F/D1-speE-R, D1-speG-F/D1-speG-R, D1-ygjG-F/
D1-ygjG-R, and D1-puuPA-F/D1-puuPA-R pairs. After 
confirmation of deletion, rpsL-neo was removed by 
another direct recombination using D2-speE, D2-speG, 
D2-ygjG, and D2-puuPA oligonucleotides.
Medium and culture conditions
For cadaverine production, the cells were aerobi-
cally cultivated in modified R/2 medium supple-
mented with 20  g/L galactose, 3  g/L (NH4)2SO4, 2  g/L 
(NH4)2HPO4, 6.75  g/L KH2PO4, 0.85  g/L citric acid, 
0.7  g/L MgSO4·7H2O, and 5  mL/L trace metal solu-
tion [1]. The trace metal solution contained 10  g/L 
FeSO4·7H2O, 2.0 g/L CaCl2·2H2O, 2.2 g/L ZnSO4·7H2O, 
0.5  g/L MnSO4, 1.0  g/L CuSO4·5H2O, 0.1  g/L 
(NH4)6Mo7O2·4H2O, and 0.02 g/L Na2B4O7·10H2O [46]. 
The pH was adjusted to 6.8 using 10 M KOH. For selec-
tion pressure, 100 μg/mL ampicillin was added to the cul-
ture medium as necessary.
The flask-scale batch culture was prepared by inocu-
lating a single colony from an LB (Lysogeny broth) 
plate to 3  mL of modified R/2 media. After overnight 
culture, the initial seed cultures were re-inoculated to 
3  mL of the same medium with optical density (OD600) 
0.05 for refreshing. When the OD600 reached 0.8–1.0, 
cells were transferred into 25 mL of fresh medium with 
OD600 of 0.05. The cells were cultured at 37 °C with con-
tinuous shaking (250  rpm). The pH of the medium was 
adjusted to 6.8 every 6 h with 10 M KOH solution. The 
culture samples were periodically withdrawn and frozen 
at −80 °C until analysis. All experiments for cell culture 
were conducted in biological duplicate. The cell mass 
was measured using a UV-1700 spectrophotometer (Shi-
madzu, Kyoto, Japan) at a wavelength of 600 nm (OD600).
For the fed-batch culture, seeds were prepared by the 
same method as described above. After refreshing, the 
cells were transferred to 2  L of modified R/2 medium 
containing 10  g/L galactose in a 5-L jar fermenter with 
an initial OD600 of 0.2. The culture broth was continu-
ously stirred at 500 rpm, and sterile air was provided at 
a flow rate of 2 vvm. The pH of the culture medium was 
automatically maintained at 6.8 with 10 M KOH solution. 
The temperature of the medium was also automatically 
controlled at 37  °C. The feeding solution [1] contain-
ing 300  g/L galactose, 8  g/L MgSO4·7H2O, and 115  g/L 
(NH4)2SO4 was used to supplement the carbon and nitro-
gen sources. A small amount of antifoam 204 (less than 
0.1% v/v) was intermittently added to prevent foaming 
during fermentation.
Analytical methods
To quantify the metabolites, the UltiMate™ 3000 ana-
lytical HPLC system (Dionex, Sunnyvale, CA, USA) was 
utilized. The concentration of galactose and acetate was 
analyzed using the Aminex HPX-87H column (Bio-Rad 
Laboratories, Richmond, CA, USA) with 5 mM H2SO4 as 
a mobile phase at a flow rate of 0.6 mL/min at 14 °C. The 
signals were monitored using a Shodex RI-101 detector 
(Shodex, Klokkerfaldet, Denmark).
For cadaverine analysis, the concentration was deter-
mined using a pre-column o-phthalaldehyde derivatiza-
tion method coupled with reverse-phase liquid column 
chromatography (Acclaim 120 C18; Dionex, Sunnyvale, 
CA, USA) [47]. The derivatized cadaverine was eluted 
at a flow rate of 0.8 mL/min with a combination of elu-
ent A (0.1  M sodium acetate in 55% methanol, pH 7.2) 
and eluent B (100% methanol) [48]. Samples with high 
cadaverine concentration were diluted to a concentra-
tion of less than 1 g/L for an accurate analysis. The signal 
was monitored using a UV–Vis diode array detector at a 
wavelength of 338 nm.
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